Arnold C. Hanish - 11 Feb 2020 Form 4/A - Amendment Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/David Arthur, as Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
11 Feb 2020
Net transactions value
+$5,002
Form type
4/A - Amendment
Filing time
06 Jun 2022, 20:28:43 UTC
Date Of Original Report
12 Feb 2020
Previous filing
06 Jun 2022
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $5,002 +4,350 +145% $1.15 7,350 11 Feb 2020 By Arnold C. Hanish Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on February 12, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.